KR910000702A - 퀴놀론 카르복실산 유도체 - Google Patents

퀴놀론 카르복실산 유도체 Download PDF

Info

Publication number
KR910000702A
KR910000702A KR1019890008595A KR890008595A KR910000702A KR 910000702 A KR910000702 A KR 910000702A KR 1019890008595 A KR1019890008595 A KR 1019890008595A KR 890008595 A KR890008595 A KR 890008595A KR 910000702 A KR910000702 A KR 910000702A
Authority
KR
South Korea
Prior art keywords
amino
carboxylic acid
compound
dihydro
oxo
Prior art date
Application number
KR1019890008595A
Other languages
English (en)
Other versions
KR920001135B1 (ko
Inventor
데루지 쓰지
히사오 사또
데쓰오 오까다
Original Assignee
요시또시 가즈오
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시또시 가즈오, 시오노기세이야꾸 가부시끼가이샤 filed Critical 요시또시 가즈오
Publication of KR910000702A publication Critical patent/KR910000702A/ko
Application granted granted Critical
Publication of KR920001135B1 publication Critical patent/KR920001135B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

퀴놀론 카르복실산 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

  1. 하기식의 화합물 또는 그것의 약제학적으로 허용되는 염;
    [식에서 R1은 C1~C4알킬이고, R2와 R3각각은 동일 또는 다르며, 수소 또는 C1~C4알킬이고, R4는 C1~C4알킬 또는 할로겐으로 임의 치환된 시클로프로필, 페닐, 할로페닐 또는 티에닐이고, 및 R5는 할로겐이다.]
  2. 제1항에 있어서, (+)-1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  3. 제1항에 있어서, (-)-1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  4. 제1항에 있어서, (+)-1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  5. 제1항에 있어서, (-)-1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  6. 제1항에 있어서, 1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  7. 제1항에 있어서, 1-(2,4-디플루오로페닐)-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  8. 제1항에 있어서, 1-티에닐-6,8-디플루오로-5-아미노-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  9. 제1항에 있어서, 1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-에톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  10. 제1항에 있어서, 1-시클로프로필-5-아미노-8-클로로-6-플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  11. 제1항에 있어서, 1-시클로프로필-5-아미노-8-클로로-6-플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  12. 제1항에 있어서, 1-시클로프로필-5-아미노-6,8-디플루오로-1,4-디히드로-7-(시스-3-메틸아미노-4-메톡시-1-피롤리디닐)-4-옥소-3-퀴놀린 카르복실산인 화합물.
  13. 활성 성분으로서 제1항에 따른 화합물의 약물학적 유효량을 함유함을 특징으로 하는 항균 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890008595A 1988-06-21 1989-06-21 퀴놀론카르복실산 유도체 KR920001135B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP63-152593 1988-06-21
JP15259388 1988-06-21
JP152593 1988-06-21
JP1058809A JPH0674261B2 (ja) 1988-06-21 1989-03-10 キノロンカルボン酸誘導体
JP058809 1989-03-10
JP89-058809 1989-03-10

Publications (2)

Publication Number Publication Date
KR910000702A true KR910000702A (ko) 1991-01-30
KR920001135B1 KR920001135B1 (ko) 1992-02-06

Family

ID=26399813

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890008595A KR920001135B1 (ko) 1988-06-21 1989-06-21 퀴놀론카르복실산 유도체

Country Status (7)

Country Link
US (1) US5106854A (ko)
EP (1) EP0347851B1 (ko)
JP (1) JPH0674261B2 (ko)
KR (1) KR920001135B1 (ko)
AU (1) AU617181B2 (ko)
DE (1) DE68910593T2 (ko)
ES (1) ES2061798T3 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
CN1054980A (zh) * 1990-02-19 1991-10-02 杏林制药株式会社 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物，它们的制备方法以及它们的中间体
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
DK0911336T3 (da) * 1996-02-27 2002-02-18 Dainippon Pharmaceutical Co Pyridoncarboxylsyrederivater og mellemprodukter til deres fremstilling
IL132982A0 (en) * 1997-05-21 2001-03-19 Daiichi Seiyaku Co Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
JPWO2003097634A1 (ja) * 2002-05-17 2005-09-15 第一製薬株式会社 キノロンカルボン酸誘導体の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
FR2634483B2 (fr) * 1987-12-29 1994-03-04 Esteve Labor Dr Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe

Also Published As

Publication number Publication date
JPH0276875A (ja) 1990-03-16
AU617181B2 (en) 1991-11-21
ES2061798T3 (es) 1994-12-16
JPH0674261B2 (ja) 1994-09-21
DE68910593D1 (de) 1993-12-16
KR920001135B1 (ko) 1992-02-06
EP0347851A1 (en) 1989-12-27
DE68910593T2 (de) 1994-04-14
US5106854A (en) 1992-04-21
AU3608089A (en) 1990-01-04
EP0347851B1 (en) 1993-11-10

Similar Documents

Publication Publication Date Title
KR920014799A (ko) 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제
KR940001883A (ko) 2-(n-(2-아미노에틸)아미노)아세트산 유도체의 용도
KR890008150A (ko) 퀴놀린 카르본산 유도체
KR870006034A (ko) 항균제로서의 5-아미노 및 5-하이드록시- 6,8-디플루오로퀴놀론
KR910000702A (ko) 퀴놀론 카르복실산 유도체
KR950702530A (ko) 프로스타글란딘 유도체
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
KR870011093A (ko) N-시아노알킬이소니코틴아미드 유도체
IE821721L (en) Imidazole derivatives
KR880002828A (ko) 디하이드로피리딘 유도체 및 이것의 약학적 조성말
IT1206130B (it) Composti per abbassare i livelli dei lipidi.
KR870006035A (ko) 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법
KR900014397A (ko) 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR900006316A (ko) 벤조 헤테로 고리화합물 및 그 제조방법
MX9206930A (es) Nuevos compuestos
KR900701262A (ko) 췌장염 등에 대한 치료제
KR890008121A (ko) 로다닌 유도체 및 약제학적 조성물
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
KR890002079A (ko) 1-[2-(페닐메틸)페닐]피페라진 및 그의 제조방법
KR890008151A (ko) 키놀린 카르복산의 유도체
NO872874L (no) Amid-derivater.
KR890003718A (ko) N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제
KR890005070A (ko) 항진균제
SE8001981L (sv) Kompositioner for behandling av glaukom

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19950925

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee